SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that their San Diego-based clinical ...

Comprehensive pharmacogenetic assay focused on psychiatry and neurology advances precision medicine for the brain. KEARNY, N.J., Nov. 21, 2024 /PRNewswire/ -- NeuroKaire, a pioneering biotechnology ...

SAN DIEGO--(BUSINESS WIRE)--Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy tests initially focused on ...

ST. LOUIS, July 29, 2025 /PRNewswire/ -- Panome Bio, a leader in advanced proteomic, metabolomic and transcriptional profiling technologies, announced it has achieved Clinical Laboratory Improvement ...

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has achieved College of American Pathologists (CAP) ...

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has achieved College of American Pathologists (CAP) ...

SEATTLE, March 7, 2024 /PRNewswire/ -- Key Proteo, a pioneering proteomics diagnostics company specializing in the early identification of rare but treatable genetic disorders, announced it has ...

SAN DIEGO, Dec. 12, 2024 /PRNewswire/ -- LuminoDx is pleased to announce that its San Diego laboratory has recently received Clinical Laboratory Improvement Amendments (CLIA) certification. CLIA ...

SAN DIEGO--(BUSINESS WIRE)--Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has achieved College of ...